Not Yet Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT07100691
Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery (GEM-GLP1RA)
Preoperative Metoclopramide to Enhance Gastric Emptying in Patients on Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss: A Randomised Controlled Trial With Ultrasound Assessment
Sponsor: Mater Misericordiae University Hospital
Conditions
Gastric Emptying Time Obesity (Disorder) Preoperative Risk Assessment Pulmonary Aspiration During Anaesthetic Induction
Interventions
Metoclopramide
Updated 1 time since 2025 Last updated: Aug 1, 2025 Started: Aug 31, 2025 Primary completion: May 31, 2026 Completion: Jun 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE4 trial investigates Gastric Emptying Time and Obesity (Disorder) and is currently actively recruiting participants. Mater Misericordiae University Hospital leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Mater Misericordiae University Hospital
Data source: Mater Misericordiae University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .